News & Media
Diplomat to Participate in Upcoming Investor Conferences
The nation’s largest independent provider of specialty pharmacy and infusion services will present at three upcoming investor conferences.
FLINT, Mich. — Aug. 30, 2018 — Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at three upcoming investor conferences.
Baird Global Healthcare Conference in New York: Atul Kavthekar, chief financial officer, will present at 9:40 a.m. ET. Sept. 5.
Wells Fargo Securities Healthcare Conference in Boston: Brian Griffin, chairman and chief executive officer, and Atul Kavthekar, chief financial officer, will present at 8 a.m. ET. Sept. 6.
Morgan Stanley Global Healthcare Conference in New York: Brian Griffin, chairman and CEO; Joel Saban, president; and Atul Kavthekar, chief financial officer, will present at 11:40 a.m. ET. Sept. 12.
Live audio webcasts of each presentation will be available on the investor relations section of Diplomat’s website at ir.diplomat.is. Recordings will be available for approximately 90 days following each presentation at the same URL.
To learn more about Diplomat, visit diplomat.is.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care. For more information, visit diplomat.is.